Zentalis Pharmaceuticals
ZNTL
Last Price
52 Week Range
$1.01 - $3.95
Next Earnings Date
May 12 2026 (Estimate)
Next Earnings Date
May 12 2026 (Est.)
Last Price
Zentalis Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Zentalis Pharmaceuticals, Inc. | 10-K | March 26, 2026 | |
Zentalis Pharmaceuticals, Inc. | 8-K | March 26, 2026 | |
Zentalis Pharmaceuticals, Inc. | 8-K | January 9, 2026 | |
Zentalis Pharmaceuticals, Inc. | 8-K | December 15, 2025 | |
Zentalis Pharmaceuticals, Inc. | 10-Q | November 10, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | November 10, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | August 26, 2025 | |
Zentalis Pharmaceuticals, Inc. | 10-Q | August 6, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | August 6, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | June 18, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | June 2, 2025 | |
Zentalis Pharmaceuticals, Inc. | DEFA14A | May 23, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | May 20, 2025 | |
Zentalis Pharmaceuticals, Inc. | 10-Q | May 14, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | May 14, 2025 | |
Zentalis Pharmaceuticals, Inc. | ARS | April 30, 2025 | |
Zentalis Pharmaceuticals, Inc. | DEF 14A | April 30, 2025 | |
Zentalis Pharmaceuticals, Inc. | DEFA14A | April 30, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | April 28, 2025 | |
Zentalis Pharmaceuticals, Inc. | 10-K | March 26, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | March 26, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | March 17, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | January 29, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | January 28, 2025 | |
Zentalis Pharmaceuticals, Inc. | 8-K | November 13, 2024 | |
Zentalis Pharmaceuticals, Inc. | 10-Q | November 12, 2024 | |
Zentalis Pharmaceuticals, Inc. | 8-K | September 16, 2024 | |
Zentalis Pharmaceuticals, Inc. | 8-K | August 9, 2024 | |
Zentalis Pharmaceuticals, Inc. | 10-Q | August 9, 2024 | |
Zentalis Pharmaceuticals, Inc. | 8-K | June 21, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.